Poolbeg Pharma PLC (POLB)

London
10.25
-0.38(-3.53%)
  • Volume:
    2,043,055
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    10.20 - 10.20

POLB Overview

Prev. Close
10.63
Day's Range
10.2-10.2
Revenue
-
Open
10.63
52 wk Range
8.33-13.3
EPS
-
Volume
2,043,055
Market Cap
51.25M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
1,279,888
P/E Ratio
-
Beta
-
1-Year Change
-
Shares Outstanding
500,000,000
Next Earnings Date
-
What is your sentiment on Poolbeg Pharma PLC?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellNeutral
Technical IndicatorsBuyStrong BuySellStrong SellStrong Buy
SummaryNeutralStrong SellStrong SellStrong SellBuy

Poolbeg Pharma PLC Company Profile

Poolbeg Pharma PLC Company Profile

Employees
0

Poolbeg Pharma PLC operates as a clinical stage infectious disease pharmaceutical company in the United Kingdom. Its products include POLB 001, a Phase-II ready p38 MAP Kinase inhibitor that reduces harmful inflammation in patients with severe forms of influenza; PredictViral Biomarker Platform, a tool for predicting severe diseases; and vaccine discovery platform, which are techniques used in human challenge models to identify vaccine candidates that drive preferential T-Cell immune responses. The company was formerly known as Orph Pharma Limited and changed its name to Poolbeg Pharma PLC in June 2021. Poolbeg Pharma PLC was incorporated in 2021 and is headquartered in London, the United Kingdom.

Read More
  • This share has some interesting products in the pipeline .It is been devolved out of Open Orphan.Well worth researching both companies-Orph gave its shareholders an exceptional dividend in POLB and is ue to announce a further 2 if not 3 dividends including a cash one before year end.
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.